semaglutide for arthritis Once-Weekly in Persons with Obesity and Knee Osteoarthritis Once-Weekly Semaglutide in Persons with
Description
Which wins for T2D control?
A new finding after stopping GLP-1 drugs in a large cohort with Type 2 diabetes: rapid erosion of CV benefit/protection New @bmj_latest by @zalaly @Biostayan See thread:
Learn more about coffee and diabetes here
Semaglutide was originally developed for type 2 diabetes, but clinical research shows it effectively reduces body weight in people without diabetes
GLP-1 medications dont just drive weight lossthey reduce inflammation, improve insulin sensitivity, and lower heart attack and stroke risk.
In conclusion, many patients receiving GLP-1RA suffer from Ozempic face and facial aging
